Jefferies lifts Hims & Hers Health Inc. [HIMS] price estimate. Who else is bullish?

Related

Hims & Hers Health Inc. [NYSE: HIMS] gained 4.93% or 0.3 points to close at $6.38 with a heavy trading volume of 2235294 shares. The company report on December 15, 2021 that Hims & Hers Expands Size & Scope of Medical Advisory Board, Adding More Diversity and Expertise.

Board’s growth comes as Hims & Hers expands into new health verticals.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform, is expanding the size and scope of its Medical Advisory Board as it continues expanding more recent medical verticals such as mental health and primary care, and further growing early focus areas, such as sexual health, dermatology, and hair loss. The Medical Advisory board — which advises the company as it works to create access to safe, high-quality care and treatment — is growing from five to 15 members. The new advisors represent a diverse group of medical experts with specific expertise in the fields of infectious disease, primary care, mental health, dermatology, sexual health, and more.

It opened the trading session at $6.12, the shares rose to $6.62 and dropped to $6.02, the range by which the price of stock traded the whole day. The daily chart for HIMS points out that the company has recorded -41.84% loss over the past six months. However, it is still -16.64% lower than its most recent low trading price.

If we look at the average trading volume of 2.49M shares, HIMS reached to a volume of 2235294 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Hims & Hers Health Inc. [HIMS]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIMS shares is $10.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIMS stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Jefferies have made an estimate for Hims & Hers Health Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on December 02, 2021. While these analysts kept the previous recommendation, Piper Sandler raised their target price from $10 to $12. The new note on the price target was released on November 11, 2021, representing the official price target for Hims & Hers Health Inc. stock. Previously, the target price had yet another raise to $12, while BofA Securities analysts kept a Neutral rating on HIMS stock.

The Average True Range (ATR) for Hims & Hers Health Inc. is set at 0.47, with the Price to Sales ratio for HIMS stock in the period of the last 12 months amounting to 6.49. The Price to Book ratio for the last quarter was 3.58, with the Price to Cash per share for the same quarter was set at 1.33.

Trading performance analysis for HIMS stock

Hims & Hers Health Inc. [HIMS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.54. With this latest performance, HIMS shares dropped by -2.60% in over the last four-week period, additionally sinking by -41.84% over the last 6 months – not to mention a drop of -56.78% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HIMS stock in for the last two-week period is set at 47.35, with the RSI for the last a single of trading hit 49.55, and the three-weeks RSI is set at 46.03 for Hims & Hers Health Inc. [HIMS]. The present Moving Average for the last 50 days of trading for this stock 7.11, while it was recorded at 6.42 for the last single week of trading, and 9.41 for the last 200 days.

Hims & Hers Health Inc. [HIMS]: A deeper dive into fundamental analysis

Return on Total Capital for HIMS is now -2.80, given the latest momentum, and Return on Invested Capital for the company is -23.51. Return on Equity for this stock declined to -23.51, with Return on Assets sitting at -19.63.

Reflecting on the efficiency of the workforce at the company, Hims & Hers Health Inc. [HIMS] managed to generate an average of -$222,491 per employee.Hims & Hers Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.00 and a Current Ratio set at 5.20.

Hims & Hers Health Inc. [HIMS]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HIMS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hims & Hers Health Inc. go to 54.30%.

>> 7 Top Picks for the Post-Pandemic Economy <<

An analysis of insider ownership at Hims & Hers Health Inc. [HIMS]

There are presently around $381 million, or 49.70% of HIMS stock, in the hands of institutional investors. The top three institutional holders of HIMS stocks are: VANGUARD GROUP INC with ownership of 10,671,442, which is approximately 21.945% of the company’s market cap and around 1.10% of the total institutional ownership; INSTITUTIONAL VENTURE MANAGEMENT XVI, LLC, holding 10,201,746 shares of the stock with an approximate value of $62.03 million in HIMS stocks shares; and INSTITUTIONAL VENTURE MANAGEMENT XV, LLC, currently with $62.03 million in HIMS stock with ownership of nearly 0.149% of the company’s market capitalization.

Positions in Hims & Hers Health Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 88 institutional holders increased their position in Hims & Hers Health Inc. [NYSE:HIMS] by around 12,148,460 shares. Additionally, 34 investors decreased positions by around 24,352,081 shares, while 11 investors held positions by with 26,226,008 shares. The mentioned changes placed institutional holdings at 62,726,549 shares, according to the latest SEC report filing. HIMS stock had 45 new institutional investments in for a total of 3,771,679 shares, while 22 institutional investors sold positions of 3,386,106 shares during the same period.